Merieux/Connaught rabies vaccine
Executive Summary
Federal Trade Commission releases Pasteur-Merieux from obligation to sell Connaught's rabies vaccine to a third party in an April 29 order, citing the company's inability to find an acceptable buyer and public health considerations. Merieux filed a motion with the FTC in December to be released from a consent order mandating the sale of the Connaught rabies vaccine ("The Pink Sheet" Jan. 17, T&G-10)